相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: Results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial
P. P. Tak et al.
ARTHRITIS AND RHEUMATISM (2012)
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial
W. Rigby et al.
ARTHRITIS AND RHEUMATISM (2012)
Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
Brad H. Rovin et al.
ARTHRITIS AND RHEUMATISM (2012)
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts
Candido Diaz-Lagares et al.
AUTOIMMUNITY REVIEWS (2012)
Long-term efficacy of anti-CD20 antibodies in refractory lupus nephritis
C. Alejandro Arce-Salinas et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Rituximab-treated membranous lupus nephritis: clinical outcome and effects on electron dense deposits
Thorunn Jonsdottir et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
B Cell Biomarkers of Rituximab Responses in Systemic Lupus Erythematosus
Edward M. Vital et al.
ARTHRITIS AND RHEUMATISM (2011)
Rituximab resistance
Andrew R. Rezvani et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2011)
Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy
Sean H. Lim et al.
BLOOD (2011)
Treatment of systemic lupus erythematosus with epratuzumab
Pawel Traczewski et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
Treatment of proliferative lupus nephritis: a slowly changing landscape
Vladimir Tesar et al.
NATURE REVIEWS NEPHROLOGY (2011)
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy
Dario Roccatello et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
Mary Anne Dooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluation
Tabitha Turner-Stokes et al.
RHEUMATOLOGY (2011)
Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma
F. Morschhauser et al.
ANNALS OF ONCOLOGY (2010)
Fc gamma RIIB, Fc gamma RIIIB, and systemic lupus erythematosus
Heather A. Niederer et al.
YEAR IN IMMUNOLOGY 2 (2010)
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
F. A. Houssiau et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
Frederic A. Houssiau et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Safety and Efficacy of Rituximab in Systemic Lupus Erythematosus
Benjamin Terrier et al.
ARTHRITIS AND RHEUMATISM (2010)
Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Eugene P. Rhee et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Updates on the Treatment of Lupus Nephritis
Andrew S. Bomback et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients
M. Garcia-Carrasco et al.
LUPUS (2010)
Use of rituximab in the treatment of refractory systemic lupus erythematosus: Singapore experience
A. Lateef et al.
LUPUS (2010)
Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus
Fausta Catapano et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts
Thorunn Jonsdottir et al.
RHEUMATOLOGY (2010)
Lifetime Trajectory of Physical Activity According to Energy Expenditure and Joint Force
Charles R. Ratzlaff et al.
ARTHRITIS CARE & RESEARCH (2010)
Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
Katerina Laskari et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Fc gamma RIIB in autoimmunity and infection: evolutionary and therapeutic implications
Kenneth G. C. Smith et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Fc gamma RIIB in autoimmunity and infection: evolutionary and therapeutic implications (vol 10, pg 328, 2010)
Kenneth G. C. Smith et al.
NATURE REVIEWS IMMUNOLOGY (2010)
A Retrospective Seven-Year Analysis of the Use of B Cell Depletion Therapy in Systemic Lupus Erythematosus at University College London Hospital: The First Fifty Patients
Tim Y-T. Lu et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
BAFF: a local and systemic target in autoimmune diseases
I. Moisini et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Rituximab in Severe Lupus Nephritis: Early B-Cell Depletion Affects Long-Term Renal Outcome
Catherine Melander et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Pathogenesis of kidney disease in systemic lupus erythematosus
Harini Bagavant et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus
C. Pena-Rossi et al.
LUPUS (2009)
Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study
John N. Boletis et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids
Ruth Pepper et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?
Edmund K. Li et al.
RHEUMATOLOGY (2009)
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis - A phase I/II randomized, blinded, placebo-controlled, dose-ranging study
Mark C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2008)
Durable Complete Responses From Therapy With Combined Epratuzumab and Rituximab Final Results From an International Multicenter, Phase 2 Study in Recurrent, Indolent, Non-Hodgkin Lymphoma
John P. Leonard et al.
CANCER (2008)
Mechanisms of disease: Systemic lupus erythematosus
Anisur Rahman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls
A. M. Jacobi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis:: results from a 10-year longitudinal study
S. W. Syversen et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
B cells in glomerulonephritis: focus on lupus nephritis
Menna R. Clatworthy et al.
SEMINARS IN IMMUNOPATHOLOGY (2007)
The long-term outcome of 93 patients with proliferative lupus nephritis
Gabriella Moroni et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Progressive multifocal leukoencephalopathy in rheumatic diseases - Evolving clinical and pathologic patterns of disease
Leonard H. Calabrese et al.
ARTHRITIS AND RHEUMATISM (2007)
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis
Iva Gunnarsson et al.
ARTHRITIS AND RHEUMATISM (2007)
Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study
Monica Vigna-Perez et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
Thomas Doerner et al.
ARTHRITIS RESEARCH & THERAPY (2006)
B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients
MJ Leandro et al.
RHEUMATOLOGY (2005)
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
EM Ginzler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis
TM Chan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand - An open-label trial
PP Sfikakis et al.
ARTHRITIS AND RHEUMATISM (2005)
Sequential therapies for proliferative lupus nephritis
G Contreras et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The classification of glomerulonephritis in systemic lupus erythematosus revisited
JJ Weening et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Treatment of diffuse proliferative lupus nephritis: A meta-analysis of randomized controlled trials
RS Flanc et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus
AT Borchers et al.
AUTOIMMUNITY REVIEWS (2004)
B cell depletion as a novel treatment for systemic lupus erythematosus - A phase I/II dose-escalation trial of rituximab
RJ Looney et al.
ARTHRITIS AND RHEUMATISM (2004)
Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients
R Cervera et al.
MEDICINE (2003)
Immunosuppressive therapy in lupus nephritis -: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
FA Houssiau et al.
ARTHRITIS AND RHEUMATISM (2002)
Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis
M Mosca et al.
KIDNEY INTERNATIONAL (2002)
Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy - Long-term followup of a cohort of 145 patients participating in randomized controlled studies
GG Illei et al.
ARTHRITIS AND RHEUMATISM (2002)
Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
TM Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
